Clinical trials
Active, not recruiting Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 3 |
| Shanghai Zhongshan Hospital | 3 |
| Eli Lilly and Company | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Arvinas Inc. | 1 |
| Asan Medical Center | 1 |
| AstraZeneca | 1 |
| Cogent Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 57 |
| Gallbladder Neoplasms | 13 |
| Carcinoma, Hepatocellular | 9 |
| Colorectal Neoplasms | 9 |
| Pancreatic Neoplasms | 8 |
| Thyroid Neoplasms | 8 |
| Biliary Tract Neoplasms | 7 |
| Bile Duct Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.